ION904

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION904, covering 2023-12-22 to 2023-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension [Phase 2]

See pricing